Trial Profile
Long-term Safety and Efficacy of Etanercept in a UK Observational Cohort Study - a Retrospective Database Analysis of British Society of Rheumatology Biologics Registry (BSRBR) Data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Pfizer
- 01 Sep 2015 Results in 1754 patients with moderate RA published in the Value in Health
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jul 2012 New trial record